Refine your search
Collections
Co-Authors
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z All
Meiyanto, Edy
- Ethanolic Extract of Moringa oleifera Increased Cytotoxic Effect of Doxorubicin on Hela Cancer Cells
Abstract Views :968 |
PDF Views:1015
Authors
Source
Journal of Natural Remedies, Vol 12, No 2 (2012), Pagination: 108-114Abstract
Moringa oleifera is a strong chemopreventive agent in several cells. The aim of this study was to investigate cytotoxic activities of ethanolic extract of Moringa oleifera (EMO) alone and in combination with doxorubicin in HeLa cancer cells. Cell viability assay of EMO, doxorubicin and combination treatments were carried out by using MTT assay. Apoptosis assay was done by double staining method using Ethidium Bromide-Acridine Orange. EMO showed cytotoxic effect in HeLa cells with IC50 >250 μg/mL. MO (5, 50 and 250 μg/mL) increased cytotoxic effect of doxorubicin compared to doxorubicin alone 100 and 200 nM. The strongest cytotoxic activity was showed by the combination of 250 nM doxorubicin and 250 μg/mL EMO. Single treatment of 250 μg/mL EMO showed weak apoptosis induction, while combination of 250 nM doxorubicin and 250 μg/mL EMO increased apoptosis induction of doxorubicin compared to 250 nM doxorubicin single treatment. Moringa oleifera is potentially to be developed as co-chemotherapeutic agent for cervical cancer, while molecular mechanism need to be explored.Keywords
Moringa oleifera, Doxorubicin, Co-chemotherapy, Cervical Cancer, Apoptosis- Curcumin and 6‑Shogaol Increase Hemoglobin F Levels by Inhibiting Expression of STAT3 mRNA Gene in K562 Line Cell
Abstract Views :240 |
PDF Views:0
Authors
Affiliations
1 Department of Biochemistry, Faculty of Medicine, University of Jenderal Soedirman, Purwokerto, ID
2 Department of Biochemistry, Faculty of Medicine, Public Health and Nursing, University of Gadjah Mada, Jogjakarta, ID
3 Cancer Chemoprevention Research Center, Faculty of Pharmacy, University of Gadjah Mada, Jogjakarta, ID
4 Department of Pharmacology, Faculty of Medicine, Public Health and Nursing, University of Gadjah Mada, Jogjakarta, ID
1 Department of Biochemistry, Faculty of Medicine, University of Jenderal Soedirman, Purwokerto, ID
2 Department of Biochemistry, Faculty of Medicine, Public Health and Nursing, University of Gadjah Mada, Jogjakarta, ID
3 Cancer Chemoprevention Research Center, Faculty of Pharmacy, University of Gadjah Mada, Jogjakarta, ID
4 Department of Pharmacology, Faculty of Medicine, Public Health and Nursing, University of Gadjah Mada, Jogjakarta, ID
Source
Indian Journal of Public Health Research & Development, Vol 11, No 1 (2020), Pagination: 1191-1196Abstract
One of the approaches for beta‑thalassemia therapy is the induction of the Haemoglobin F (Hb F). Curcumin and 6‑Shogaol are empirically known to induce HbF, but the signalling cascade has not been widely explained. This study aims to uncover the potential of Curcumin and 6‑shogaol in inhibiting the expression of STAT3 mRNA gene. This study uses the K562 erythroleukemic line cell model with an experimental design post‑test only with a control group. There are 5 groups, each group has 3 replications, named the control group without treatment, the positive control group with Hydroxyurea treatment (75 μM), the combination treatment group of Curcumin (2 μM) and 6‑Shogaol (10 μM), the single curcumin (2 μM) treatment group and a single 6‑Shogaol (10 μM) treatment group. Test samples were taken in 72‑h and 96‑h time series, then RNA extraction from the cell line was continued by cDNA synthesis. The expression of STAT3 mRNA gene was measured using the qRT‑PCR technique; then, the Hb F level was measured by the ELISA method. Statistical analysis using ANOVA test with significance level p <0.05. In the 72‑h time series, there was a significant decrease in STAT3 Gena mRNA expression (p <0.05). The lowest single curcumin group (p <0.01) followed by a single 6‑Shogaol group (p <0.05) compared to the untreated control group, while the positive control group with hydroxyurea treatment and the Curcumin and 6‑shogaol combination treatment groups are not significant. Hb F levels, there was an increase in 96‑h time series (p <0.05) respectively from highest to lowest in the curcumin group (p <0.05), 6‑shogaol (p> 0.05) compared to the control group, but in the positive control group (p> 0.05) and the combination group (p> 0.05) it is lower than the control group without any treatment.Curcumin and 6‑shogaol increase Hb F levels through inhibition expression of STAT3 mRNA Gene on K562 cells. The results of this study could be the basis for further research in vivo to reveal the signalling pathway in Hb Finduction therapy.Keywords
Curcumin, 6‑shogaol, STAT3 Gena mRNA, Hemoglobin F, K562 cells- Curcumin and 6-Shogaol Increase Hemoglobin F Levels by Inhibiting Expression of STAT3 mRNA Gene in K562 Line Cell
Abstract Views :458 |
PDF Views:0
Authors
Affiliations
1 Department of Biochemistry, Faculty of Medicine, University of Jenderal Soedirman, Purwokerto, ID
2 Department of Biochemistry, Faculty of Medicine, Public Health and Nursing, University of Gadjah Mada, Jogjakarta, ID
3 Cancer Chemoprevention Research Center, Faculty of Pharmacy, University of Gadjah Mada, Jogjakarta, ID
4 Department of Pharmacology, Faculty of Medicine, Public Health and Nursing, University of Gadjah Mada, Jogjakarta, ID
1 Department of Biochemistry, Faculty of Medicine, University of Jenderal Soedirman, Purwokerto, ID
2 Department of Biochemistry, Faculty of Medicine, Public Health and Nursing, University of Gadjah Mada, Jogjakarta, ID
3 Cancer Chemoprevention Research Center, Faculty of Pharmacy, University of Gadjah Mada, Jogjakarta, ID
4 Department of Pharmacology, Faculty of Medicine, Public Health and Nursing, University of Gadjah Mada, Jogjakarta, ID